Comparative Pharmacology
Head-to-head clinical analysis: PEG 3350 AND ELECTROLYTES versus POLYETHYLENE GLYCOL 3350.
Head-to-head clinical analysis: PEG 3350 AND ELECTROLYTES versus POLYETHYLENE GLYCOL 3350.
PEG 3350 AND ELECTROLYTES vs POLYETHYLENE GLYCOL 3350
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PEG 3350 is an osmotic laxative that retains water in the bowel lumen via hydrogen bonding, increasing fecal water content and stimulating peristalsis. Electrolytes (sodium sulfate, potassium chloride, sodium bicarbonate, magnesium sulfate) prevent significant fluid and electrolyte shifts by maintaining isotonicity.
Osmotic laxative. Polyethylene glycol 3350 is a non-absorbable polymer that retains water in the colon via hydrogen bonding, increasing stool water content and stimulating defecation.
4 liters orally of the reconstituted solution administered as a single dose at 240 mL every 10 minutes or 1 to 1.5 L/hour until rectal effluent is clear. Alternatively, 240 mL every 10 minutes until 4 L consumed.
17 g (1 capful or packet) dissolved in 4–8 oz (120–240 mL) water, administered orally once daily for constipation; for colonoscopy preparation, 240 g (4 L of solution) ingested at 240 mL every 10–15 minutes.
None Documented
None Documented
Not applicable; PEG 3350 undergoes minimal systemic absorption (<0.2%), thus no meaningful terminal half-life. Systemic half-life of absorbed fraction is <2 hours.
Terminal elimination half-life is 1-2 hours in patients with normal renal function; prolonged in renal impairment, but clinical impact minimal due to primarily fecal elimination.
Primarily fecal (96–98%) as unabsorbed PEG 3350; electrolytes absorbed are excreted renally (sodium, potassium) and via feces (biliary excretion negligible).
Renal: approximately 20% excreted unchanged; Fecal: approximately 80% eliminated unchanged in feces.
Category C
Category C
Osmotic Laxative
Osmotic Laxative